以围肝门切除为本的肝门部胆管癌治愈性切除术的临床疗效

New types of operation based on perihilar resection to cure hilar cholangiocarcinoma

  • 摘要: 目的:探讨以围肝门切除为本的肝门部胆管癌治愈性切除术的临床疗效。
    方法:采用回顾性描述性研究方法。收集2014年12月至2016年6月清华大学附属清华长庚医院收治的4例不同 Bismuth分型肝门部胆管癌患者的临床病理资料。经术前检查和评估后制订对应的手术策略,患者行单独围肝门切除术或围肝门切除联合中央区域肝段切除术。观察指标:(1)术中情况。(2)术后病理学检查结果。(3)术后情况。(4)随访情况。采用门诊方式进行随访,随访内容为:腹痛、发热等一般状况,血常规和肿瘤标志物检查,影像学检查判断肿瘤有无复发和转移。随访时间截至2017年6月。计量资料以平均数(范围)表示。
    结果:(1)术中情况:4例患者均顺利完成手术,平均手术时间为512 min(300~620 min);采用持续门静脉阻断的入肝血流阻断方式,平均阻断时间为70 min(57~80 min);平均术中出血量为537 mL(200~1 000 mL);2例术中分别输注2 U血浆、4 U血浆+4 U RBC。(2)术后病理学检查结果:4例患者术后病理学检查结果显示:肿瘤大小分别为1.5 cm×1.2 cm×1.1 cm、1.3 cm×1.1 cm×1.0 cm、2.0 cm×1.7 cm×1.5 cm、2.0 cm×2.0 cm×1.5 cm;肿瘤分化程度:1例为中分化胆管腺癌,3例为低分化胆管腺癌。4例患者肝门区的神经侵犯均为阳性,3例淋巴结转移阳性。4例患者均为R0切除。4例患者TNM分期:1例T2aN1M0期,3例T2bN1M0期。(3)术后情况:4例患者中,1例术后发生胆汁漏,经保守治疗后痊愈,术后第67天出院;3例术后恢复顺利,并于术后21、14、14 d出院。术后未进行放化疗等辅助治疗。(4)随访情况:4例患者均获得随访,随访时间为12~31个月,随访期间患者一般状况均良好,1例发生一过性发热,经保守治疗后缓解。4例患者肿瘤标志物均在正常范围内,增强CT检查结果显示无肿瘤复发征象,肝内胆管无扩张。
    结论:在精确评估肝段胆管支受累的基础上采用围肝门切除或联合中央区域肝段切除可以有效治疗肝门部胆管癌。

     

    Abstract: Objective:To explore clinical efficacy of new types of operation based on perihilar resection to cure hilar cholangiocarcinoma.
    Methods:The retrospective descriptive study was conducted. The clinicopathological data of 4 patients with different Bismuth type of hilar cholangiocarcinoma who were admitted to the Beijing Tsinghua Chunggung Hospital from December 2014 to June 2016 were collected. After preoperative examinations and evaluations, single perihilar resection or combined with central liver segmentectomy were performed. Observation indicators included: (1) intraoperative situations; (2) postoperative pathological examinations; (3) postoperative situations; (4) followup. Patients were followed up using outpatient examination up to June 2017. Followup included abdominal pain, fever, routine blood test, tumor marker test and imaging examination which detected tumor recurrence and metastasis. Measurement data were represented as average (range).
    Results:(1) Intraoperative situations: 4 patients received successful operations, with an average operation time of 512 minutes (range, 300-620 minutes). Portal vein was blocked continuously, with an average occlusion time of 70 minutes (range, 57-80 minutes), an average volume of intraoperative blood loss was 537 mL (range, 200-1 000 mL). Two patients received transfusion of 2 U plasma, 4 U plasma + 4 U red blood cell (RBC), respectively. (2) Postoperative pathological examinations: results of postoperative pathological examinations in 4 patients showed that tumor size was respectively 1.5 cm×1.2 cm× 1.1 cm, 1.3 cm×1.1 cm×1.0 cm, 2.0 cm×1.7 cm×1.5 cm and 2.0 cm×2.0 cm×1.5 cm. Tumor differentiation: 1 and 3 patients were respectively detected in moderatedifferentiated cholangiocarcinoma and lowdifferentiated cholangiocarcinoma. Positive nerve plexus invasion was found in all 4 patients and 3 patients had regional lymph node metastasis. Four patients received R0 resection. TNM staging: T2aN1M0 and T2bN1M0 were found in 1 and 3 patients, respectively. (3) Postoperative situations: of 4 patients, 1 complicated with biliary leakage was cured by conservative treatment and then discharged from hospital at 67 days; 3 had good recovery and then discharged from hospital at day 21, 14 and 14, respectively. Patients didn′t receive postoperative adjuvant treatment, such as chemoradiotherapy. (4) Followup: 4 patients were followed up for 12-31 months. During followup, 4 patients were in good condition, and 1 with transient fever was relieved by conservative treatment. Levels of tumor marker in 4 patients were normal, results of enhanced CT scan showed no signs of tumor recurrence and intrahepatic bile duct dilatation.
    Conclusion:After precisely evaluating the tumor extension among segmental bile duct, single perihilar resection or combined with central segmentectomy can effectively cure hilar cholangiocarcinoma.

     

/

返回文章
返回